Document Type

Thesis

Date of Degree Completion

Spring 2012

Degree Name

Bachelor of Science

Department

Chemistry

Committee Chair

Dr. Levente Fabry-Astalos, Department of Chemistry

Second Committee Member

Dr. Gil Belofsky, Department of Chemistry

Third Committee Member

Dr. Audrey D. Huerta, Director Science Honors Research Program

Abstract

Currently, approximately 33.3 million people are living with HIV/AIDS worldwide and each year an additional 2.1 million people become infected. The goal of this research is to develop 1,3-azaborines that could potentially inhibit HIV-1 protease. HIV-1 protease is an enzyme involved in the protein processing step of the replication cycle. By inhibiting HIV-1 protease, the drug would slow the progression of HIV into AIDS. The target compounds are expected to have both competitive and associative inhibition and may inhibit mutated HIV viruses as well. To synthesize these compounds, boronic acids were coupled with a chiral directing/protecting group. A homologation was then performed to insert a chlorinated carbon. The chlorine was then replaced with hexamethyldisilazane. Attempts are being made toward cyclization which would result in 1,3-azaborines, which can be coupled with tripeptides to yield potential HIV-1 protease inhibitors.

Comments

This thesis has been digitized and made available as part of the University’s ongoing preservation and access initiatives. Copyright is retained by the original author. The University has made a good faith effort to review this work for copyright and privacy concerns prior to digitization. If you are the author or a rights holder and have questions, concerns or wish to request removal, please contact ScholarWorks@cwu.edu.

Included in

Chemistry Commons

Share

COinS